GTHX Wutah pendapatan triwulanan G1 Therapeutics

Simbol lan logo merek g1therapeutics.com (GTHX)

G1 Therapeutics, Inc. (GTHX) generates revenue based on the sale of Cosela for lung cancer patients. This chart of quarterly revenue reflects this trend, where -61.10 represents the current metric. Stability is driven by monopoly pricing power derived from bone marrow protection, as well as a strong team of biotechnologists and logistics experts.

g1therapeutics.com (GTHX) - Tingkat wutah pendapatan sajrone kuartal saka 04.07.2022 nganti 28.09.2024

G1 Pharma (GTHX) - rincian metrik lan laporan keuangan

- kuotasi saiki lan rata-rata prakiraan nilai:
Analisis umum perusahaan:g1therapeutics.com (GTHX)
Barang unggulan G1 Therapeutics Inc.

This metric measures the relative quarterly revenue dynamics with daily recalculations, allowing investors to differentiate systemic business development from short-term market fluctuations. By analyzing the quarterly revenue growth trend, one can assess the integration efficiency of G1 Therapeutics, Inc. (GTHX) into the international holding structure, where the stabilization of cash flows following the acquisition should transform into sustainable organic growth of operating assets.

Pesaing utama

INCY - Wutah pendapatan kuartal marang kuartal|Owah-owahan pendapatan dibandhingake kuartal kepungkur HUTCHMED (HCM)|NUVB: Wutah pendapatan triwulanan|Owah-owahan pendapatan dibandhingake kuartal kepungkur Day One Bio DAWN|Wutah dodolan triwulanan MNPR|Tingkat wutah pendapatan sajrone kuartal Inhibrx Biosciences INBX|Wutah dodolan triwulanan IMAB (I-Mab Biopharma Co., Ltd.)|FENC (Fennec Pharmaceuticals Inc.) - Tambahing pendapatan triwulanan|Heron Therapeutics, Inc. - Wutah dodolan triwulanan|Owah-owahan dodolan kuartal marang kuartal NVCT (Nuvectis Pharma)|Coherus BioSciences, Inc. - Wutah pendapatan triwulanan|Tambahing pendapatan triwulanan CRBP (Corbus Pharma)|CRDF: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal beyondspringpharma.com (BYSI)|Wutah pendapatan kuartal marang kuartal bioatla.com|LIXT: Tambahing pendapatan triwulanan|Wutah pendapatan triwulanan CTXR|Wutah pendapatan triwulanan Cellectar Corp (CLRB)|Wutah pendapatan kuartal marang kuartal BioLineRx Corp BLRX|CANF (Can-Fite BioPharma Ltd.) - Dinamika pendapatan kuartal marang kuartal|APRE: Wutah dodolan triwulanan|Tingkat wutah pendapatan sajrone kuartal Kazia Therapeutics Limited|Silexion Therapeutics Corp (SLXN) - Wutah pendapatan kuartal marang kuartal|Wutah dodolan kuartal marang kuartal NCNA|CMRX (Chimerix, Inc.) - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Cyclacel Pharmaceuticals CYCC|Wutah pendapatan kuartal marang kuartal Kronos Bio Corporation (KRON)|Kintara - Wutah dodolan kuartal marang kuartal|Oncternal Therapeutics, Inc. - Wutah dodolan triwulanan|Owah-owahan dodolan kuartal marang kuartal PRTG (Portage)